Enter your login e-mail to the account
Search
Search parameters
Search results
- Early highefficacy mulitple sclerosis treatment: therapeutic success despite safety barriers
MUDr. Dominika Šťastná, Ph.D., prof. MUDr. Manuela Vaněčková, Ph.D., doc. MUDr. Dana Horáková, Ph.D.
(6/2023, Case reports ) - Ocrelizumab since the first multiple sclerosis attack – a milestone in reimbursement criteria
MUDr. Dominika Šťastná, MUDr. Ingrid Menkyová, doc. MUDr. Dana Horáková, Ph.D.
(4/2022, Review articles ) - High efficacy treatment since the first attack – an important step in the treatment of multiple sclerosis?
MUDr. Dominika Šťastná, MUDr. Ingrid Menkyová, doc. MUDr. Dana Horáková, Ph.D.
(1/2023, Review articles ) - High-efficacy drugs in early stage of multiple sclerosis
MUDr. Veronika Tichá, Ph.D.
(5/2022, Review articles ) - Treatment of multiple sclerosis in Czech Republic – options and reality
MUDr. Michal Dufek
(1/2014, Review articles )
- Criteria of the oncology drugs categorisation process on use of the principle „the value for money“ from the point of view of expected benefits
MVDr., Mgr. Peter Mrva, MPH
(2/2017, Main topic ) - Quantification of the impact of cost-effectiveness threshold on cancer drugs reimbursement in Slovakia
RNDr. Mária Pšenková, MPH, Mgr. Marek Psota, PhD., Ing. Martin Suchanský, doc. RNDr. Martina Ondrušová, PhD., MPH
(2/2017, Main topic ) - Publikujeme v zahraničí
(2/2012, Information & comments ) - Publikujeme v zahraničí
redakcia
(3/2018, Information & comments )